1. Cohen ZA, McCarthy DM, Kwak SD, Legrand P, Fogarasi F, Ciaccio EJ, Ateshian GA (1999) Knee cartilage topography, thickness, and contact areas from MRI: in-vitro calibration and in-vivo measurements. Osteoarthr Cartil 7(1):95–109
2. van Valburg AA, Wenting MJ, Beekman B, Te Koppele JM, Lafeber FP, Bijlsma JW (1997) Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: comparison with clinically defined osteoarthritic cartilage. J Rheumatol 24(2):358–364
3. Martini FH et al (2001) Fundamentals of anatomy and physiology, 5th edn. Prentice Hall, Upper Saddle River, New Jersey
4. Lequesne M, Brandt K, Bellamy N, Moskowitz R, Menkes CJ, Pclletier JP, Altman RD (1994) Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol 21(suppl 41):GS-73
5. Dougados M, Devogelaer JP, Annefeld M, Avouac B, Bouvenot G, Cooper C, the Members of the Group for the Respect of Ethics and Excellence in Science et al (1996) Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 55:552–557